Decreased hepcidin mRNA expression in thalassemic mice - PubMed (original) (raw)

Decreased hepcidin mRNA expression in thalassemic mice

Konstantin Adamsky et al. Br J Haematol. 2004 Jan.

Free article

No abstract available

PubMed Disclaimer

Similar articles

• Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection.
  Hendy OM, Allam M, Allam A, Attia MH, El Taher S, Eldin MM, Ali A. Hendy OM, et al. Egypt J Immunol. 2010;17(2):33-44. Egypt J Immunol. 2010. PMID: 23082485
• Effects of iron overload condition on liver toxicity and hepcidin/ferroportin expression in thalassemic mice.
  Kumfu S, Chattipakorn SC, Fucharoen S, Chattipakorn N. Kumfu S, et al. Life Sci. 2016 Apr 1;150:15-23. doi: 10.1016/j.lfs.2016.02.082. Epub 2016 Feb 24. Life Sci. 2016. PMID: 26921633
• Role of iron in inducing oxidative stress in thalassemia: Can it be prevented by inhibition of absorption and by antioxidants?
  Rachmilewitz EA, Weizer-Stern O, Adamsky K, Amariglio N, Rechavi G, Breda L, Rivella S, Cabantchik ZI. Rachmilewitz EA, et al. Ann N Y Acad Sci. 2005;1054:118-23. doi: 10.1196/annals.1345.014. Ann N Y Acad Sci. 2005. PMID: 16339657 Review.
• [An iron regulator hepcidin is affected by EPO].
  Sun XF, Zhou DB, Zhao YQ. Sun XF, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Aug;14(4):778-82. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006. PMID: 16928320 Chinese.
• Hepcidins in amphibians and fishes: Antimicrobial peptides or iron-regulatory hormones?
  Shi J, Camus AC. Shi J, et al. Dev Comp Immunol. 2006;30(9):746-55. doi: 10.1016/j.dci.2005.10.009. Epub 2005 Nov 14. Dev Comp Immunol. 2006. PMID: 16325907 Review.

Cited by

• Transferrin therapy ameliorates disease in beta-thalassemic mice.
  Li H, Rybicki AC, Suzuka SM, von Bonsdorff L, Breuer W, Hall CB, Cabantchik ZI, Bouhassira EE, Fabry ME, Ginzburg YZ. Li H, et al. Nat Med. 2010 Feb;16(2):177-82. doi: 10.1038/nm.2073. Epub 2010 Jan 24. Nat Med. 2010. PMID: 20098432
• Fetal factors disrupt placental and maternal iron homeostasis in murine β-thalassemia.
  Yu Y, Woloshun RR, Lee JK, Ebea PO, Zhu S, Nemeth E, Garrick LM, Garrick MD, Collins JF. Yu Y, et al. Blood. 2023 Jul 13;142(2):185-196. doi: 10.1182/blood.2022018839. Blood. 2023. PMID: 37146247 Free PMC article.
• Iron metabolism: interactions with normal and disordered erythropoiesis.
  Ganz T, Nemeth E. Ganz T, et al. Cold Spring Harb Perspect Med. 2012 May;2(5):a011668. doi: 10.1101/cshperspect.a011668. Cold Spring Harb Perspect Med. 2012. PMID: 22553501 Free PMC article. Review.
• SEC23B Loss-of-Function Suppresses Hepcidin Expression by Impairing Glycosylation Pathway in Human Hepatic Cells.
  Rosato BE, Marra R, D'Onofrio V, Del Giudice F, Della Monica S, Iolascon A, Andolfo I, Russo R. Rosato BE, et al. Int J Mol Sci. 2022 Jan 24;23(3):1304. doi: 10.3390/ijms23031304. Int J Mol Sci. 2022. PMID: 35163229 Free PMC article.
• Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in beta-thalassemia.
  Libani IV, Guy EC, Melchiori L, Schiro R, Ramos P, Breda L, Scholzen T, Chadburn A, Liu Y, Kernbach M, Baron-Lühr B, Porotto M, de Sousa M, Rachmilewitz EA, Hood JD, Cappellini MD, Giardina PJ, Grady RW, Gerdes J, Rivella S. Libani IV, et al. Blood. 2008 Aug 1;112(3):875-85. doi: 10.1182/blood-2007-12-126938. Epub 2008 May 14. Blood. 2008. PMID: 18480424 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wiley

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)